Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

49
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

71
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

49
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

3.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

58
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
58
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

68
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental Exposures and Atherosclerotic Risk Factors in Vulnerable Youth: The Example of American Indian/Alaska Native Populations.

Current atherosclerosis reports·2026
Same author

A 2-year randomized trial of pitavastatin calcium vs placebo to treat combined dyslipidemia in adolescents with overweight and obesity.

Journal of clinical lipidology·2026
Same author

Cost-Effectiveness of Familial Hypercholesterolemia Screening in Childhood and Early Adulthood.

JAMA·2026
Same author

Environmental Justice in Vulnerable Populations: Climate Change and Congenital Heart Disease in American Indian/Alaska Native Children.

Journal of racial and ethnic health disparities·2026
Same author

Periodontal Disease and Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Circulation·2025
Same author

Environmental Risk in American Indian Children, Including Cardiovascular and Hematologic Consequences of Cadmium Exposure: Possible Means of Mitigation.

International journal of environmental research and public health·2025
Same journal

Centering Lived Experience: Inclusive Pediatric Care for Children Who Are Deaf and Hard of Hearing and Their Families.

Pediatric annals·2026
Same journal

From Early Childhood to Adulthood: Implementing Neuroaffirming Health Care for Autistic Individuals.

Pediatric annals·2026
Same journal

Neurodivergence in Medical Education: Current Landscape and Inclusive Future for Pediatrics.

Pediatric annals·2026
Same journal

Neurodiversity and Intellectual Disability: Opportunities and Challenges for Functioning and Participation Across the Life Course.

Pediatric annals·2026
Same journal

Action for Access: Equity for Children With Disabilities in Lowand Middle-Income Countries.

Pediatric annals·2026
Same journal

Rethinking "Healthy" for Every Child: Building Flexible, Family Centered Routines in a Neurodiverse World.

Pediatric annals·2026
See all related articles

Related Experiment Video

Updated: Nov 4, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.3K

Pediatric Lipid Disorders.

Scott Leopold, Justin P Zachariah

    Pediatric Annals
    |May 26, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Atherosclerosis begins in childhood and can be managed through lifestyle changes and medication. Early intervention in pediatric patients is crucial for preventing future cardiovascular events.

    More Related Videos

    Lipid Exchange Assay in Living Cells
    08:59

    Lipid Exchange Assay in Living Cells

    Published on: March 21, 2025

    769
    Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
    07:12

    Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

    Published on: June 2, 2023

    7.9K

    Related Experiment Videos

    Last Updated: Nov 4, 2025

    Assessing Whole-Body Lipid-Handling Capacity in Mice
    07:57

    Assessing Whole-Body Lipid-Handling Capacity in Mice

    Published on: November 24, 2020

    4.3K
    Lipid Exchange Assay in Living Cells
    08:59

    Lipid Exchange Assay in Living Cells

    Published on: March 21, 2025

    769
    Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
    07:12

    Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

    Published on: June 2, 2023

    7.9K

    Area of Science:

    • Pediatric Cardiology
    • Cardiovascular Disease Prevention
    • Lipid Metabolism Disorders

    Background:

    • Atherosclerosis is a progressive condition starting in childhood, leading to adult cardiovascular events.
    • The rising prevalence of childhood obesity and genetic lipid disorders necessitates pediatric management strategies.
    • Childhood presents a critical window for intervening in atherosclerosis development.

    Purpose of the Study:

    • To highlight the importance of understanding and managing pediatric lipid disorders.
    • To emphasize the opportunity for early intervention in atherosclerosis.
    • To outline current management approaches for childhood atherosclerosis.

    Main Methods:

    • Review of current scientific evidence on childhood atherosclerosis.
    • Analysis of the role of lifestyle interventions (diet, physical activity).
    • Consideration of pharmacotherapy in pediatric lipid management.

    Main Results:

    • Atherosclerosis initiates in childhood and progresses into adulthood.
    • Lifestyle modifications are primary management strategies.
    • Pharmacotherapy may be indicated in specific pediatric cases.

    Conclusions:

    • Early detection and management of lipid disorders in children are essential.
    • Targeted interventions can modify or reverse atherosclerosis progression.
    • A comprehensive approach involving lifestyle and, when necessary, medication is key for pediatric cardiovascular health.